Reaktionsgleichung
[CH:1]1([CH2:6][OH:7])[CH2:5][CH2:4][CH2:3][CH2:2]1.F[C:9]1[CH:10]=[C:11]([CH3:18])[CH:12]=[CH:13][C:14]=1[N+:15]([O-:17])=[O:16].[CH:19]1([CH2:24][O:25][C:26]2[CH:32]=[C:31]([CH3:33])[CH:30]=[CH:29][C:27]=2[NH2:28])[CH2:23][CH2:22][CH2:21][CH2:20]1.[NH2:34][C:35]1[S:36][CH:37]=[CH:38][N:39]=1>>[CH:1]1([CH2:6][O:7][C:9]2[CH:10]=[C:11]([CH3:18])[CH:12]=[CH:13][C:14]=2[N+:15]([O-:17])=[O:16])[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:19]1([CH2:24][O:25][C:26]2[CH:32]=[C:31]([CH3:33])[CH:30]=[CH:29][C:27]=2[NH:28][C:6]([NH:34][C:35]2[S:36][CH:37]=[CH:38][N:39]=2)=[O:7])[CH2:20][CH2:21][CH2:22][CH2:23]1Komponenten
6
Edukt 4
Produkt 2
Versuchsvorschrift
3-Cyclopentylmethoxy-4-nitrotoluene (0.82 g, 70%) was prepared from cyclopentylmethanol and 3-fluoro-4-nitrotoluene (0.77 g, 5.0 mmol) following the general procedure G. This was reduced to 2-cyclopentylmethoxy-4-methyl-aniline (0.58 g, 81%) following general procedure C. 1-(2-Cyclopentylmethoxy-4-methyl-phenyl)-3-thiazol-2-yl-urea (225 mg, 68%) was prepared from 2-cyclopentylmethoxy-4-methyl-aniline (205 mg, 1.0 mmol) and 2-aminothiazole (100 mg, 1.0 mmol) following the general procedure D.
Quellen und Nachweise
- ORD-Eintrag
- ord-ef15e105545f4a25a74632b1ecfcafea
- Quelldatensatz
- uspto-grants-2008_06
- Patentnummer
- US07384967B2
Verknüpfte Notizen
Wird geladen…